AICR awards $1.15 million for cancer prevention and survivorship

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Seven researchers have received a total of $1.15 million from the American Institute for Cancer Research to study the relationship between diet, nutrition, physical activity, body weight and cancer prevention and survivorship.

The diverse research topics focus on cancers in women and men and identify a wide array of the most common risk factors and their impact on prevention, survivorship and recurrence.

The 2021 AICR research grantees are:

  • Christine Brainson, University of Kentucky Research Foundation: How dietary methionine influences lung cancer initiation and chemosensitivity,
  • Michael De Lisio, University of Ottawa: Aberrant myelopoiesis as a novel mechanism for the differential effects of obesity and exercise on colorectal cancer risk,
  • Brian Focht, Ohio State University: Addressing obesity to reduce cancer risk and health disparities in underserved populations,
  • Christopher Haiman, University of Southern California: Interactions of polygenic risk score with BMI, physical activity and dietary patterns on risk of breast, colorectal and prostate cancer in the Multiethnic Cohort,
  • Xin Lu, University of Notre Dame: Overcome resistance to cancer immunotherapy with ketogenic diet-induced epigenetic reprogramming,
  • Scherezade Mama, MD Anderson Cancer Center: Feasibility of an adapted multicomponent physical activity intervention to reduce psychosocial distress in rural adults following cancer diagnosis; and
  • Erik Nelson, University of Illinois at Urbana-Champaign: Determining the impact of different preparation techniques of foods high in cholesterol on breast cancer progression.

AICR has contributed more than $110 million to support over 750 studies conducted at universities, hospitals and research centers across North, South and Central America.

Table of Contents

YOU MAY BE INTERESTED IN

Those of us who have devoted our careers to treating recalcitrant cancers know the heartbreak of walking alongside an individual facing an advanced diagnosis. We not only shoulder the clinical responsibility, but also the emotional weight that accompanies every step of that journey as each patient’s story becomes connected to our own.
If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login